- Home
- UAA vs OGN Comparison
UAA vs OGN Comparison
Compare UAA & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAA
- OGN
- Stock Information
- Founded
- UAA 1996
- OGN 1923
- Country
- UAA United States
- OGN United States
- Employees
- UAA N/A
- OGN N/A
- Industry
- UAA Apparel
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- UAA Consumer Discretionary
- OGN Health Care
- Exchange
- UAA Nasdaq
- OGN Nasdaq
- Market Cap
- UAA 4.4B
- OGN 3.9B
- IPO Year
- UAA N/A
- OGN N/A
- Fundamental
- Price
- UAA $8.61
- OGN $14.50
- Analyst Decision
- UAA Hold
- OGN Hold
- Analyst Count
- UAA 20
- OGN 3
- Target Price
- UAA $9.19
- OGN $21.33
- AVG Volume (30 Days)
- UAA 9.8M
- OGN 4.5M
- Earning Date
- UAA 02-06-2025
- OGN 02-13-2025
- Dividend Yield
- UAA N/A
- OGN 7.68%
- EPS Growth
- UAA N/A
- OGN 120.97
- EPS
- UAA N/A
- OGN 5.04
- Revenue
- UAA $5,400,928,000.00
- OGN $6,409,000,000.00
- Revenue This Year
- UAA N/A
- OGN $3.11
- Revenue Next Year
- UAA $1.45
- OGN $2.55
- P/E Ratio
- UAA N/A
- OGN $2.89
- Revenue Growth
- UAA N/A
- OGN 4.21
- 52 Week Low
- UAA $6.17
- OGN $13.58
- 52 Week High
- UAA $11.89
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- UAA 39.74
- OGN 37.20
- Support Level
- UAA $10.00
- OGN $14.39
- Resistance Level
- UAA $8.86
- OGN $15.15
- Average True Range (ATR)
- UAA 0.44
- OGN 0.52
- MACD
- UAA -0.20
- OGN -0.02
- Stochastic Oscillator
- UAA 18.30
- OGN 8.63
About UAA Under Armour Inc.
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.